Viewing StudyNCT03983161


Ignite Creation Date: 2025-12-17 @ 1:42 PM
Ignite Modification Date: 2025-12-23 @ 11:08 PM
Study NCT ID: NCT03983161
Status: COMPLETED
Last Update Posted: 2023-03-17
First Post: 2019-06-10
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment
Sponsor: Celgene
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-09-04
Start Date Type: ACTUAL
Primary Completion Date: 2023-01-05
Primary Completion Date Type: ACTUAL
Completion Date: 2023-01-05
Completion Date Type: ACTUAL
First Submit Date: 2019-06-10
First Submit QC Date: None
Study First Post Date: 2019-06-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-16
Last Update Post Date: 2023-03-17
Last Update Post Date Type: ACTUAL